Two Sigma Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5M | Buy |
23,000
+700
| +3% | +$155K | ﹤0.01% | 1977 |
|
|
2025
Q4 | $5.1M | Buy |
22,300
+11,300
| +103% | +$2.57M | 0.01% | 1710 |
|
|
2025
Q3 | $2.55M | Buy |
+11,000
| New | +$2.24M | ﹤0.01% | 1967 |
|
|
2022
Q1 | – | Sell |
-53,800
| Closed | -$7.29M | – | 2552 |
|
|
2021
Q4 | $7.29M | Sell |
53,800
-17,100
| -24% | -$2.02M | 0.02% | 974 |
|
|
2021
Q3 | $7.65M | Sell |
70,900
-129,200
| -65% | -$14.8M | 0.02% | 912 |
|
|
2021
Q2 | $22.5M | Buy |
200,100
+76,900
| +62% | +$8.66M | 0.05% | 448 |
|
|
2021
Q1 | $13.3M | Sell |
123,200
-400
| -0.3% | -$42.8K | 0.03% | 586 |
|
|
2020
Q4 | $13.2M | Sell |
123,600
-58,100
| -32% | -$5.58M | 0.04% | 494 |
|
|
2020
Q3 | $15.9M | Buy |
181,700
+111,300
| +158% | +$10.5M | 0.06% | 357 |
|
|
2020
Q2 | $6.91M | Sell |
70,400
-8,100
| -10% | -$713K | 0.03% | 517 |
|
|
2020
Q1 | $5.98M | Sell |
78,500
-5,300
| -6% | -$451K | 0.05% | 427 |
|
|
2019
Q4 | $7.42M | Sell |
83,800
-61,600
| -42% | -$5.11M | 0.02% | 750 |
|
|
2019
Q3 | $11M | Sell |
145,400
-13,200
| -8% | -$905K | 0.04% | 518 |
|
|
2019
Q2 | $11.5M | Buy |
158,600
+132,300
| +503% | +$10.4M | 0.04% | 537 |
|
|
2019
Q1 | $2.12M | Sell |
26,300
-108,700
| -81% | -$8.89M | 0.01% | 1384 |
|
|
2018
Q4 | $12.4M | Buy |
135,000
+70,600
| +110% | +$6.21M | 0.05% | 480 |
|
|
2018
Q3 | $6.09M | Sell |
64,400
-128,500
| -67% | -$12.2M | 0.02% | 861 |
|
|
2018
Q2 | $17.9M | Buy |
192,900
+180,300
| +1,431% | +$17.6M | 0.05% | 444 |
|
|
2018
Q1 | $1.19M | Sell |
12,600
-226,000
| -95% | -$24.8M | ﹤0.01% | 1881 |
|
|
2017
Q4 | $23.1M | Buy |
238,600
+225,000
| +1,654% | +$21.2M | 0.08% | 344 |
|
|
2017
Q3 | $1.21M | Sell |
13,600
-131,600
| -91% | -$10M | ﹤0.01% | 1614 |
|
|
2017
Q2 | $10.5M | Sell |
145,200
-31,600
| -18% | -$2.12M | 0.04% | 502 |
|
|
2017
Q1 | $11.5M | Sell |
176,800
-71,300
| -29% | -$4.48M | 0.04% | 570 |
|
|
2016
Q4 | $15.5M | Buy |
248,100
+148,700
| +150% | +$9.08M | 0.06% | 394 |
|
|
2016
Q3 | $6.27M | Buy |
99,400
+31,400
| +46% | +$2.03M | 0.02% | 766 |
|
|
2016
Q2 | $4.21M | Sell |
68,000
-134,000
| -66% | -$8.17M | 0.02% | 844 |
|
|
2016
Q1 | $11.5M | Buy |
202,000
+132,000
| +189% | +$7.36M | 0.06% | 400 |
|
|
2015
Q4 | $4.15M | Buy |
+70,000
| New | +$4.03M | 0.02% | 737 |
|
|
2015
Q3 | – | Sell |
-167,000
| Closed | -$11.2M | – | 2125 |
|
|
2015
Q2 | $11.2M | Buy |
167,000
+150,000
| +882% | +$9.79M | 0.05% | 411 |
|
|
2015
Q1 | $995K | Buy |
+17,000
| New | +$1.03M | ﹤0.01% | 1591 |
|
Other funds holding ABBV
VCM
VPM
Two Sigma Investments's ABBV Position: Q1 2026 in Review
Two Sigma Investments increased its AbbVie (ABBV) stake by 56% in Q1 2026, buying an estimated $14.1M and bringing the position to 178,418 shares worth $38.8M. The position accounts for 0.03% of the portfolio, ranked #607.
Two Sigma Investments first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $261M in Q4 2021. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Two Sigma Investments held 178,418 shares of AbbVie worth $38.8M as of Q1 2026.
- Two Sigma Investments bought 63,706 AbbVie shares in Q1 2026, an estimated $14.1M.
- AbbVie made up 0.03% of Two Sigma Investments's portfolio in Q1 2026, its #607 holding.
- Two Sigma Investments first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Two Sigma Investments's AbbVie position peaked at $261M in Q4 2021.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.